Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2003
02/12/2003EP1283055A1 Soluble beta amyloid precursor protein secretion promoters
02/12/2003EP1283054A1 Drugs for complications of diabetes and neuropathy and utilization thereof
02/12/2003EP1283050A2 Improved therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
02/12/2003EP1283048A1 Therapeutic agent for improving bladder function or treating urinary disturbance and food and drink containing it
02/12/2003EP1283046A1 Preventives and/or remedies for hyperphosphatemia
02/12/2003EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody
02/12/2003EP1283044A2 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
02/12/2003EP1283043A1 Ophthalmic solution
02/12/2003EP1283042A1 Aqueous liquid preparation
02/12/2003EP1283041A1 Pharmaceutical compositions containing HIV-protease inhibitors
02/12/2003EP1283040A1 Sustained release oral preparations
02/12/2003EP1283039A1 -secretase inhibitors
02/12/2003EP1283038A1 Compositions normalizing circadian rhythm
02/12/2003EP1283036A1 Dry powder for inhalation
02/12/2003EP1283034A2 Agglomerates of beta-lactam antibiotics
02/12/2003EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor
02/12/2003EP1282700A1 Neuronal serine-threonine protein kinase
02/12/2003EP1282699A2 Splice-region antisense composition and method
02/12/2003EP1282684A2 Chondroitin synthase gene and methods of making and using same
02/12/2003EP1282631A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
02/12/2003EP1282626A2 Polyketide derivatives
02/12/2003EP1282625A1 Benzoxazines for use in the treatment of parkinson's disease
02/12/2003EP1282624A1 Crf receptor antagonists and methods relating thereto
02/12/2003EP1282623A1 Pyrazolo-triazine derivatives as ligands for gaba receptors
02/12/2003EP1282622A1 Crf receptor antagonists and methods relating thereto
02/12/2003EP1282621A1 Novel vitronectin receptor antagonists
02/12/2003EP1282620A1 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
02/12/2003EP1282619A1 Processes for the preparation of thiazolidinedione derivatives and intermediates
02/12/2003EP1282618A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
02/12/2003EP1282617A1 Hydantoin derivatives with affinity for somatostatin receptors
02/12/2003EP1282616A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
02/12/2003EP1282615A1 Chroman derivatives as estrogenic compounds
02/12/2003EP1282614A1 Hydroxamic acid derivatives
02/12/2003EP1282613A1 A pharmaceutical composition containing the extract of saururus chinensis baill useful as and anticancer agent and a process for the preparation thereof
02/12/2003EP1282612A2 Alkynyl phenyl heteroaromatic glucokinase activators
02/12/2003EP1282611A1 Substituted phenylacetamides and their use as glucokinase activators
02/12/2003EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
02/12/2003EP1282609A2 Piperazinedione compounds
02/12/2003EP1282607A2 Prodrugs of hiv replication inhibiting pyrimidines
02/12/2003EP1282606A2 Hiv replication inhibiting pyrimidines and triazines
02/12/2003EP1282604A1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
02/12/2003EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists
02/12/2003EP1282600A1 Inhibitors of dipeptidyl peptidase iv
02/12/2003EP1282599A1 Disulfide derivatives useful for treating allergic diseases
02/12/2003EP1282592A2 Use of amines
02/12/2003EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells
02/12/2003EP1282447A1 Stable polymeric micelle-type drug composition and method for the preparation thereof
02/12/2003EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders
02/12/2003EP1282443A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
02/12/2003EP1282440A1 Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumor agents
02/12/2003EP1282436A2 Treatment of acute coronary syndrome with glp-1
02/12/2003EP1282430A2 Immune response modulation
02/12/2003EP1282429A1 Pharmaceutical gel composition
02/12/2003EP1282427A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection
02/12/2003EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
02/12/2003EP1282424A1 compositions for enhancing the immune response
02/12/2003EP1282423A2 Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with ns398 or pdtc
02/12/2003EP1282422A1 Ciprofloxacin infusion solutions with improved storage life
02/12/2003EP1282421A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain
02/12/2003EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
02/12/2003EP1282419A2 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
02/12/2003EP1282418A2 Use of pyrazole derivatives for treating infertility
02/12/2003EP1282417A1 Creatinine biosensor
02/12/2003EP1282416A2 Dehydroascorbic acid formulations and uses thereof
02/12/2003EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis
02/12/2003EP1282414A2 Felbamate derived compounds
02/12/2003EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
02/12/2003EP1282412A1 Treating irritable bowel syndrome or disease
02/12/2003EP1282411A1 Method of treating cancer
02/12/2003EP1282410A2 Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists
02/12/2003EP1282409A1 Insulin formulation for inhalation
02/12/2003EP1282408A1 Hydrogel composition for transdermal drug delivery
02/12/2003EP1282406A1 Pharmaceutical kit comprising midodrine as an active drug substance
02/12/2003EP1282404A2 Method for preparing microparticles having a selected polymer molecular weight
02/12/2003EP1282403A1 Non-invasive gene targeting to the brain
02/12/2003EP1282402A1 Stabilized aqueous suspensions for parenteral use
02/12/2003EP1282401A2 Stabilized steroidal suspension
02/12/2003EP1282399A2 Rapidly disintegrating solid oral dosage form
02/12/2003EP1282396A1 Anti-pollution composition based on anthocyanic pigments
02/12/2003EP1282395A1 Use of ellagic acid as anti-pollution cosmetic agent
02/12/2003EP1282394A1 Use of n,n'-dibenzyl ethylene diamine n,n'-diacetic acid derivatives as anti-pollution agent
02/12/2003EP1282393A1 External application for enhancing the skin permeability of the active components therein
02/12/2003EP1282366A2 Compositions containing folic acid and reduced folate
02/12/2003EP1282365A2 Preparation for the prevention and/or treatment of vascular disorders
02/12/2003EP1189899B1 Pyrazinone thrombin inhibitors
02/12/2003EP1124566B1 Non-fermented osmotic laxative for treating and preventing colorectal cancers
02/12/2003EP1109534B1 Quick release pharmaceutical compositions of drug substances
02/12/2003EP1104414B1 Enantioselective synthesis
02/12/2003EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments
02/12/2003EP1054679B1 Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear
02/12/2003EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
02/12/2003EP1042355B1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments
02/12/2003EP1032584B1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them
02/12/2003EP1032566B1 Method for the preparation of citalopram
02/12/2003EP1023314B1 Bile acid salts of metals with physiological action and the use thereof in therapy
02/12/2003EP1023294B1 Carbapenem derivatives and a preparation method thereof
02/12/2003EP1019088B1 Composition for the treatment of nicotine addiction containing mecamylamine and bupropion
02/12/2003EP1003724B1 Substituted quinoline derivatives with antiviral action
02/12/2003EP1003542B1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
02/12/2003EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents
1 ... 5565 5566 5567 5568 5569 5570 5571 5572 5573 5574 5575 5576 5577 5578 5579 5580 5581 5582 5583 5584 5585 ... 7860